A novel approach for aerosol therapy education: simulation-based program

<bold>Introduction:</bold> There is a considerable body of evidence supporting the use of Aerogen vibrating mesh nebuliser technology. Following the recently published consensus statement on aerosol therapy in critically ill patients, the objective of this pilot course was to educate physicians on aerosol therapy, gain insights in current clinical practice, understand gaps in the published literature and educational needs and improve relationships with physicians. <bold>Methods:</bold> This meeting was held in the AQAI Simulation centre in Germany and comprised of three elements (Fig 1). Previously published in vitro studies were replicated using an advanced patient simulation across various modes of respiratory support. Imaging studies examining aerosol deposition were visualised through a 3D lung model. Clinical studies were presented by experts in aerosol drug delivery. 10 physicians were in attendance and answered a questionnaire. <fig><object-id>erj;64/suppl_68/PA2573/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig> Figure 1. <bold>Results:</bold> At the end of the program, 70% of attendees acknowledged the course's efficacy in enhancing their competence in aerosol drug delivery across modalities. 50-60% of attendees said they need to establish local protocols and educational courses to integrate this technology as their practice's standard of care. <bold>Conclusions:</bold> This peer-to-peer approach provides a platform to educate and train health care professionals on the complexities of respiratory drug delivery in pulmonology, critical care and emergency care settings.